Drugs from nature targeting inflammation: in discussion with Atanas Atanasov
MedChemNet discusses DNTI, an interdisciplinary network project with success in identifying novel drug candidates for inflammation, with Atanas Atanasov, one of the project’s collaborators.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.